Company Data

Prelude Therapeutics Incorporated

Ticker
PRLD
Current Price
$0.8709 -3.5%
Market Cap
$47.9M
Price Target
Refer to Report
Volume
161.1K
52wk Range
$0.7966 - $6.8
Advanced Market Data

Overview

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy